Drug major Pfizer Inc. (PFE) announced Monday positive topline results from the progression-free survival or PFS analysis of the ...

Pfizer has announced that its Braftovi (encorafenib) regimen significantly improved both progression-free and overall ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

The plaintiff alleged that Pfizer illegally barred whites and Asians from applying for its Breakthrough Fellowship Program.

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

Since taking over in late 2023, Alex Chriss, PayPal chief executive, has focused on high-margin products and touted ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

Dubai-based Select Group acquired Radisson Blu Hotel, Dubai Media City, in a deal valued at over 200 million UAE dirhams ($54 ...

In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Buy rating on Endeavour Mining (EDV – Research Report), with a ...

Pfizer will receive all of the net proceeds ... including the United States, Canada, South Africa, Australia or Japan. Neither this announcement nor anything contained herein shall form the ...